Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial. (Q40899766)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial. |
scientific article |
Statements
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial (English)
Anita Kohli
Sarah Kattakuzhy
Sreetha Sidharthan
Mary McLaughlin
Cassie Seamon
Eric G Meissner
Zayani Sims
Rachel Silk
Chloe Gross
Elizabeth Akoth
Lydia Tang
Angie Price
Tim A Jolley
Benjamin Emmanuel
Michael Proschan
Gebeyehu Teferi
Jose Chavez
Stephen Abbott
Anuoluwapo Osinusi
Hongmei Mo
Michael A Polis